AI assistant
Rezolute, Inc. — Director's Dealing 2025
Feb 21, 2025
32362_dirs_2025-02-20_d0b654ea-5699-4797-8cc5-9c88ea00dd06.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Rezolute, Inc. (RZLT)
CIK: 0001509261
Period of Report: 2025-02-16
Reporting Person: Hogenhuis Wladimir (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-16 | Common Shares | A | 25500 | — | Acquired | 67267 | Direct |
| 2025-02-18 | Common Shares | P | 10000 | $4.7 | Acquired | 77267 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-16 | Director Stock Option (Right to Buy) | $4.61 | A | 15000 | Acquired | 2035-02-16 | Common Shares (15000) | Direct |
Footnotes
F1: Represents grant of restricted stock units which vest 100% on March 1, 2026.
F2: The options vest 100% on March 1, 2026.
F3: The purchase price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.69 to $4.70, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.